Bumrungrad Hospital Public Company Limited
Bumrungrad Hospital Public Company Limited owns and operates hospitals in Thailand and internationally. It offers services in the areas of allergy, arrhythmia, behavioural health, breast, home, heart valve, robotic surgery, rehabilitation, spine, paediatrics, colorectal surgery, complex coronary artery intervention, comprehensive sleep, cornea transplant, dental, diagnostic, dialysis, radiology a… Read more
Bumrungrad Hospital Public Company Limited (BUHPF) - Net Assets
Latest net assets as of June 2025: $28.96 Billion USD
Based on the latest financial reports, Bumrungrad Hospital Public Company Limited (BUHPF) has net assets worth $28.96 Billion USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($33.76 Billion) and total liabilities ($4.80 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $28.96 Billion |
| % of Total Assets | 85.78% |
| Annual Growth Rate | 15.87% |
| 5-Year Change | 47.59% |
| 10-Year Change | 112.21% |
| Growth Volatility | 14.06 |
Bumrungrad Hospital Public Company Limited - Net Assets Trend (2003–2024)
This chart illustrates how Bumrungrad Hospital Public Company Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Bumrungrad Hospital Public Company Limited (2003–2024)
The table below shows the annual net assets of Bumrungrad Hospital Public Company Limited from 2003 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $27.80 Billion | +15.37% |
| 2023-12-31 | $24.10 Billion | +20.46% |
| 2022-12-31 | $20.01 Billion | +13.55% |
| 2021-12-31 | $17.62 Billion | -6.47% |
| 2020-12-31 | $18.84 Billion | -7.05% |
| 2019-12-31 | $20.27 Billion | +8.11% |
| 2018-12-31 | $18.74 Billion | +12.21% |
| 2017-12-31 | $16.70 Billion | +12.96% |
| 2016-12-31 | $14.79 Billion | +12.88% |
| 2015-12-31 | $13.10 Billion | +16.35% |
| 2014-12-31 | $11.26 Billion | +17.33% |
| 2013-12-31 | $9.60 Billion | +14.42% |
| 2012-12-31 | $8.39 Billion | +24.56% |
| 2011-12-31 | $6.73 Billion | +10.95% |
| 2010-12-31 | $6.07 Billion | +10.91% |
| 2009-12-31 | $5.47 Billion | +12.48% |
| 2008-12-31 | $4.87 Billion | +11.87% |
| 2007-12-31 | $4.35 Billion | +19.86% |
| 2006-12-31 | $3.63 Billion | +34.60% |
| 2005-12-31 | $2.70 Billion | +30.85% |
| 2004-12-31 | $2.06 Billion | +63.57% |
| 2003-12-31 | $1.26 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Bumrungrad Hospital Public Company Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 2675333324000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $26.07 Billion | 94.86% |
| Common Stock | $794.92 Million | 2.89% |
| Other Comprehensive Income | $-152.24 Million | -0.55% |
| Other Components | $770.70 Million | 2.80% |
| Total Equity | $27.49 Billion | 100.00% |
Bumrungrad Hospital Public Company Limited Competitors by Market Cap
The table below lists competitors of Bumrungrad Hospital Public Company Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Bill Com Holdings Inc
NYSE:BILL
|
$3.32 Billion |
|
NH Investment & Securities Co Ltd
KO:005940
|
$3.32 Billion |
|
HAIDILAO INT.HLDG LTD
F:8HI
|
$3.32 Billion |
|
KB Home
NYSE:KBH
|
$3.32 Billion |
|
JDE Peet's N.V
PINK:JDEPF
|
$3.32 Billion |
|
Denison Mines Corp
NYSE MKT:DNN
|
$3.32 Billion |
|
Adtalem Global Education Inc
NYSE:ATGE
|
$3.32 Billion |
|
JSC National Atomic Company Kazatomprom
PINK:NATKY
|
$3.32 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Bumrungrad Hospital Public Company Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 23,801,128,648 to 27,487,679,879, a change of 3,686,551,231 (15.5%).
- Net income of 7,774,725,876 contributed positively to equity growth.
- Dividend payments of 4,101,253,278 reduced retained earnings.
- Other comprehensive income increased equity by 8,617,803.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $7.77 Billion | +28.28% |
| Dividends Paid | $4.10 Billion | -14.92% |
| Other Comprehensive Income | $8.62 Million | +0.03% |
| Other Changes | $4.46 Million | +0.02% |
| Total Change | $- | 15.49% |
Book Value vs Market Value Analysis
This analysis compares Bumrungrad Hospital Public Company Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.15x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 3.36x to 0.15x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2003-12-31 | $1.44 | $4.85 | x |
| 2004-12-31 | $2.39 | $4.85 | x |
| 2005-12-31 | $3.01 | $4.85 | x |
| 2006-12-31 | $4.18 | $4.85 | x |
| 2007-12-31 | $5.01 | $4.85 | x |
| 2008-12-31 | $5.61 | $4.85 | x |
| 2009-12-31 | $6.31 | $4.85 | x |
| 2010-12-31 | $7.00 | $4.85 | x |
| 2011-12-31 | $7.76 | $4.85 | x |
| 2012-12-31 | $9.67 | $4.85 | x |
| 2013-12-31 | $11.06 | $4.85 | x |
| 2014-12-31 | $12.55 | $4.85 | x |
| 2015-12-31 | $14.68 | $4.85 | x |
| 2016-12-31 | $16.69 | $4.85 | x |
| 2017-12-31 | $18.91 | $4.85 | x |
| 2018-12-31 | $21.28 | $4.85 | x |
| 2019-12-31 | $23.03 | $4.85 | x |
| 2020-12-31 | $21.36 | $4.85 | x |
| 2021-12-31 | $19.93 | $4.85 | x |
| 2022-12-31 | $22.72 | $4.85 | x |
| 2023-12-31 | $27.44 | $4.85 | x |
| 2024-12-31 | $31.69 | $4.85 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Bumrungrad Hospital Public Company Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 28.28%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 30.23%
- • Asset Turnover: 0.79x
- • Equity Multiplier: 1.19x
- Recent ROE (28.28%) is above the historical average (27.04%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2003 | 53.78% | 14.43% | 1.04x | 3.60x | $542.55 Million |
| 2004 | 45.36% | 16.09% | 1.16x | 2.44x | $728.53 Million |
| 2005 | 40.25% | 15.47% | 1.19x | 2.19x | $791.22 Million |
| 2006 | 30.20% | 13.88% | 1.19x | 1.83x | $732.85 Million |
| 2007 | 36.92% | 17.06% | 1.26x | 1.72x | $1.17 Billion |
| 2008 | 24.48% | 13.41% | 1.10x | 1.67x | $704.51 Million |
| 2009 | 22.76% | 13.34% | 1.09x | 1.57x | $698.39 Million |
| 2010 | 20.73% | 12.50% | 1.10x | 1.51x | $651.55 Million |
| 2011 | 23.59% | 14.42% | 0.82x | 2.00x | $914.86 Million |
| 2012 | 31.79% | 20.54% | 0.82x | 1.89x | $1.83 Billion |
| 2013 | 26.27% | 17.57% | 0.83x | 1.80x | $1.56 Billion |
| 2014 | 25.09% | 17.47% | 0.82x | 1.76x | $1.64 Billion |
| 2015 | 26.98% | 19.46% | 0.83x | 1.67x | $2.16 Billion |
| 2016 | 25.05% | 20.24% | 0.84x | 1.47x | $2.18 Billion |
| 2017 | 24.04% | 21.50% | 0.78x | 1.43x | $2.30 Billion |
| 2018 | 22.50% | 22.66% | 0.74x | 1.34x | $2.31 Billion |
| 2019 | 18.76% | 20.29% | 0.71x | 1.31x | $1.75 Billion |
| 2020 | 6.50% | 9.74% | 0.51x | 1.31x | $-649.02 Million |
| 2021 | 7.03% | 9.76% | 0.60x | 1.21x | $-512.93 Million |
| 2022 | 25.06% | 23.83% | 0.85x | 1.23x | $2.97 Billion |
| 2023 | 29.44% | 27.61% | 0.87x | 1.23x | $4.63 Billion |
| 2024 | 28.28% | 30.23% | 0.79x | 1.19x | $5.03 Billion |
Industry Comparison
This section compares Bumrungrad Hospital Public Company Limited's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $250,407,165
- Average return on equity (ROE) among peers: -38.80%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Bumrungrad Hospital Public Company Limited (BUHPF) | $28.96 Billion | 53.78% | 0.17x | $3.32 Billion |
| Addus HomeCare Corporation (ADUS) | $113.86 Million | 16.82% | 0.44x | $1.75 Billion |
| agilon health Inc (AGL) | $126.73 Million | -319.84% | 9.03x | $166.17 Million |
| Airsculpt Technologies Inc (AIRS) | $123.68 Million | 6.13% | 0.45x | $16.62 Million |
| Amedisys Inc (AMED) | $454.23 Million | -18.40% | 0.61x | $3.26 Billion |
| AMN Healthcare Services Inc (AMN) | $347.86 Million | 23.54% | 1.53x | $624.22 Million |
| American Shared Hospital Service (AMS) | $20.85 Million | 8.48% | 1.33x | $7.93 Million |
| American Oncology Network Inc. (AONC) | $226.04 Million | -0.05% | 0.10x | $112.23 Million |
| Ardent Health Partners, Inc. (ARDT) | $1.08 Billion | 4.65% | 3.71x | $225.22 Million |
| Arem Pacific Corporation (ARPC) | $-45.09K | 0.00% | 0.00x | $246.12K |
| Astrana Health Inc (ASTH) | $8.55 Million | -109.27% | 1.29x | $1.08 Billion |